EBOS Group Stock

EBOS Group P/CF

The P/CF (Price-to-Cash-Flow Ratio) of EBOS Group (EBO.NZ) as of Aug 10, 2026 is 9.07. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 10.90 — a change of -16.79% (lower).

P/CF

9.07

YoY

-16.79%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of EBOS Group is 2026 9.07 . P/CF (Price-to-Cash-Flow Ratio) of EBOS Group was 2025 10.90 . It decreases by -16.79% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

EBOS Group Stock analysis

What does EBOS Group do? The EBOS Group was founded in New Zealand in 2000 and has since grown to become one of the largest healthcare companies in the region. The company's business model is to provide solutions for the healthcare industry, ranging from products for pharmacies, hospitals, and medical practices to healthcare services. The company is divided into several divisions, including healthcare distribution, dental, and healthcare services. The healthcare distribution division focuses on distributing pharmaceutical products, medical devices, and other healthcare items to healthcare facilities. This includes surgical instruments and oncology products. The dental division specializes in selling and distributing dental products, such as instruments for dentists and consumables like gloves, implants, and floss. They also offer services for dentists, including a dental practice built in partnership with another company. The healthcare services division includes the distribution of home care and healthcare products, as well as the rental of medical equipment like wheelchairs and beds. EBOS Group also provides services such as consultation and training for patients, caregivers, and healthcare providers. With a strong emphasis on quality and customer satisfaction, EBOS Group has a successful track record and has acquired and developed several companies in the region. Their products help improve patient health and contribute to reducing healthcare costs. The company plays a vital role in the healthcare products and services market. The EBOS Group's diverse divisions and wide range of products secure its position as an important player in the healthcare industry. EBOS Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EBOS Group stock

P/CF (Price-to-Cash-Flow Ratio) of EBOS Group is 9.07 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of EBOS Group changed from 10.90 to 9.07, representing a -16.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) EBOS Group since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s EBOS Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — EBOS Group

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — EBOS Group